Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of GBP 10.32 million. The enterprise value is 3.05 million.

Market Cap	10.32M
Enterprise Value	3.05M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+15.30%
Shares Change (QoQ)	+53.66%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	13.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.21
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.22

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.15.

Current Ratio	2.30
Quick Ratio	1.89
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -148.12% and return on invested capital (ROIC) is -89.50%.

Return on Equity (ROE)	-148.12%
Return on Assets (ROA)	-67.08%
Return on Invested Capital (ROIC)	-89.50%
Return on Capital Employed (ROCE)	-234.14%
Revenue Per Employee	n/a
Profits Per Employee	-439,773
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.74% in the last 52 weeks. The beta is 2.09, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	2.09
52-Week Price Change	+27.74%
50-Day Moving Average	0.87
200-Day Moving Average	1.06
Relative Strength Index (RSI)	48.52
Average Volume (20 Days)	2,944

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.74

Income Statement

Revenue	n/a
Gross Profit	-1.25M
Operating Income	-15.63M
Pretax Income	-15.47M
Net Income	-14.51M
EBITDA	-15.43M
EBIT	-15.63M
Earnings Per Share (EPS)	-1.42

Full Income Statement

Balance Sheet

The company has 7.69 million in cash and 944,694 in debt, giving a net cash position of 6.75 million.

Cash & Cash Equivalents	7.69M
Total Debt	944,694
Net Cash	6.75M
Net Cash Per Share	n/a
Equity (Book Value)	6.11M
Book Value Per Share	0.42
Working Capital	5.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.58 million and capital expenditures -10,918, giving a free cash flow of -13.59 million.

Operating Cash Flow	-13.58M
Capital Expenditures	-10,918
Free Cash Flow	-13.59M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.30%
Shareholder Yield	-15.30%
Earnings Yield	-140.57%
FCF Yield	-131.67%

Dividend Details

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	0.0666666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a